AOBiome Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AOBiome's estimated annual revenue is currently $2.8M per year.(i)
  • AOBiome's estimated revenue per employee is $155,000

Employee Data

  • AOBiome has 18 Employees.(i)
  • AOBiome grew their employee count by 6% last year.

AOBiome's People

NameTitleEmail/Phone
1
CFO and SVP ManufacturingReveal Email/Phone
2
VP, Manufacturing Operations & QualityReveal Email/Phone
3
SVP Strategic Alliances and CommunicationsReveal Email/Phone
4
VP Research & DevelopmentReveal Email/Phone
5
Senior Director, Research & DevelopmentReveal Email/Phone
6
Chief Staff & Director Program ManagementReveal Email/Phone
7
Director, Manufacturing and Supply ChainReveal Email/Phone
8
President and CEOReveal Email/Phone
9
Inventor and FounderReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is AOBiome?

AOBiome Therapeutics, Inc. is a Cambridge, MA-based life sciences company focused on transforming human health by developing microbiome-based therapies for local, nasal and systemic inflammatory conditions. Founded in 2012 by PatientsLikeMe founder Jamie Heywood and MIT-trained Chemical Engineer David Whitlock, AOBiome is advancing a pipeline of multiple, clinical-stage therapeutic candidates. The company's portfolio includes multiple clinical-stage programs: a completed Phase 2 study to treat patients with acne vulgaris or acne, a Phase 1b study to treat patients with pediatric eczema (atopic dermatitis), a Phase 2a study to treat patients with adult eczema (atopic dermatitis), a Phase 2 study for the prevention of episodic migraines, and a Phase 1b/2a clinical trial for the treatment of allergic rhinitis, as well as earlier-stage preclinical programs targeting diverse inflammatory indications.

keywords:N/A

N/A

Total Funding

18

Number of Employees

$2.8M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

AOBiome News

2022-04-13 - Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference

AOBiome Therapeutics, a clinical stage biotechnology company focused on transforming human health by developing topical biologic therapies for...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.1M18-10%$161M
#2
$3.5M18N/AN/A
#3
$1.6M18N/AN/A
#4
$2.5M18-14%N/A
#5
$3.5M18-40%N/A